Acusensus Limited (ACE.AX)
AUD 1.1
(-3.51%)
AUD 1.1
(-3.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.57 Million | 4.25 Million | 4.96 Million | -1 Million | -1.43 Million | -34 Thousand |
| Net Income | -1.52 Million | 55.37 Thousand | 1.42 Million | -3.64 Million | -1.25 Million | -121 Thousand |
| Depreciation & Amortization | 6.3 Million | 4.68 Million | 3.18 Million | 514.73 Thousand | 142 Thousand | 23 Thousand |
| Deferred income taxes | - | -14.52 Million | -6.73 Million | 796.78 Thousand | - | - |
| Stock-based compensation | 1.42 Million | 405.81 Thousand | 248.67 Thousand | 955.03 Thousand | - | - |
| Change in working capital | -2.42 Million | -1.11 Million | 92.37 Thousand | -1.75 Million | -592.51 Thousand | - |
| Other non-cash items | -205 Thousand | 14.74 Million | 6.75 Million | 2.13 Million | 268.51 Thousand | 64 Thousand |
| Investing Cash Flow | -7.51 Million | -17.37 Million | -7.24 Million | -3.16 Million | -839 Thousand | -222 Thousand |
| Investments in PPE | -7.51 Million | -5.37 Million | -7.24 Million | -2.84 Million | -719 Thousand | -222 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -12 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.94 Million | -13.39 Million | -425.6 Thousand | -319.98 Thousand | -120 Thousand | - |
| Financing Cash Flow | -1.47 Million | 17.33 Million | -1.44 Million | 15.38 Million | 2.25 Million | 1.34 Million |
| Debt repayment | -1.59 Million | -1.28 Million | -287.95 Thousand | -880.36 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 121 Thousand | 18.62 Million | - | 15.13 Million | 2.25 Million | - |
| Other Financing Activities | -1.59 Million | -1.28 Million | -1.44 Million | 1.13 Million | -325.00 | 1.34 Million |
| Accounts receivables | -2.97 Million | -5.16 Million | -2.21 Million | -1.05 Million | -829.22 Thousand | - |
| Accounts payables | 168 Thousand | -108.25 Thousand | 2.85 Million | 2.83 Million | 262.29 Thousand | - |
| Inventory | 109 Thousand | 528.13 Thousand | -755.08 Thousand | -692.76 Thousand | -269.38 Thousand | - |
| Other working capital | 445 Thousand | 3.63 Million | 210.11 Thousand | -2.83 Million | 243.8 Thousand | - |
| Cash at beginning of period | 12.79 Million | 8.6 Million | 12.32 Million | 1.11 Million | - | - |
| Cash at end of period | 7.34 Million | 12.79 Million | 8.6 Million | 12.32 Million | 1.11 Million | 1.08 Million |
| Capital Expenditure | -7.51 Million | -5.37 Million | -7.24 Million | -2.84 Million | -719 Thousand | -222 Thousand |
| Effect of forex changes on cash | -41 Thousand | -25.32 Thousand | - | 348.00 | 1.13 Million | - |
| Net cash flow / Change in cash | -5.45 Million | 4.19 Million | -3.72 Million | 11.21 Million | 1.11 Million | 1.08 Million |
| Free Cash Flow | -3.94 Million | -1.11 Million | -2.27 Million | -3.84 Million | -2.15 Million | -256 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.52 Million | -1.28 Million | -241.43 Thousand | 318.17 Thousand | 55.37 Thousand | -262.8 Thousand |
| Depreciation & Amortization | 6.3 Million | 3.31 Million | 2.98 Million | 2.63 Million | 4.68 Million | 2.04 Million |
| Deferred income taxes | - | - | -4.9 Million | -7.04 Million | -14.52 Million | -7.47 Million |
| Stock-based compensation | - | 741.95 Thousand | 681.04 Thousand | 207.64 Thousand | 405.81 Thousand | 198.16 Thousand |
| Change in working capital | -3.05 Million | -676.45 Thousand | -1.74 Million | 2.08 Million | -1.11 Million | -3.19 Million |
| Other non-cash items | 17.16 Million | 1.02 Million | 3.68 Million | 7.04 Million | 14.74 Million | 7.69 Million |
| Investing Cash Flow | -7.51 Million | -4.19 Million | -3.32 Million | -15.73 Million | -17.37 Million | -1.63 Million |
| Investments in PPE | -7.51 Million | -3.2 Million | -3.32 Million | -3.73 Million | -5.37 Million | -1.63 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -12 Million | -12 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -985.52 Thousand | -963.48 Thousand | -12.87 Million | -13.39 Million | -523.54 Thousand |
| Financing Cash Flow | -1.47 Million | -788.78 Thousand | -683.21 Thousand | 19.29 Million | 17.33 Million | -1.95 Million |
| Debt repayment | - | - | -798.21 Thousand | - | -1.28 Million | -577.56 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 121 Thousand | 6000.00 | 115 Thousand | 20 Million | 18.62 Million | -1.37 Million |
| Other Financing Activities | - | -788.78 Thousand | 115 Thousand | 19.29 Million | -1.28 Million | -1.37 Million |
| Accounts receivables | -2.97 Million | -1.47 Million | -1.5 Million | -1.44 Million | -5.16 Million | -3.72 Million |
| Accounts payables | 168 Thousand | - | - | -696.48 Thousand | -108.25 Thousand | 588.22 Thousand |
| Inventory | 109 Thousand | 505.67 Thousand | -396.67 Thousand | 575.99 Thousand | 528.13 Thousand | -47.86 Thousand |
| Other working capital | -353 Thousand | 290.29 Thousand | 154.7 Thousand | 3.37 Million | 3.63 Million | -18.1 Thousand |
| Cash at beginning of period | 12.79 Million | 9.14 Million | 12.79 Million | 3.99 Million | 8.6 Million | 8.6 Million |
| Cash at end of period | 7.34 Million | 7.34 Million | 9.14 Million | 12.79 Million | 12.79 Million | 3.99 Million |
| Capital Expenditure | -7.51 Million | -3.2 Million | -3.32 Million | -3.73 Million | -5.37 Million | -1.63 Million |
| Effect of forex changes on cash | - | 53.22 Thousand | -94.22 Thousand | -1421.00 | -25.32 Thousand | -23.9 Thousand |
| Net cash flow / Change in cash | -5.45 Million | -1.8 Million | -3.64 Million | 8.8 Million | 4.19 Million | -4.61 Million |
| Free Cash Flow | -3.94 Million | -84.21 Thousand | -2.87 Million | 1.51 Million | -1.11 Million | -2.63 Million |
MITT-PA
CHEMPLASTS
9590
ACESOFT
002037
300841